Synopsis of Chitosan Market:
Globally, the Chitosan Market is growing at a CAGR of 18.02% during forecasted period (2016-2022). Chitosan is produced commercially deacetylation of chitin, which is the structural element in the exoskeleton of crustaceans namely shrimps, oyster, crabs and other mollusk shells and cell wall of fungi. Besides , the properties of chitosan are antibacterial, anti-fungal and anti-viral due to these properties they are driving the market, application is huge in pharmaceutical industry namely, wound dressings, surgical sutures and as aids in cataracts surgery and periodontal diseases treatment. Availability of chitosan is enormous in nature, it ranks second as the most plentiful organic compound on earth. Chitosan has many properties that make them attractive for application from food, nutrition, cosmetics, biomedicine, and agriculture.
Globally, Chitosan Market was valued at USD 2.05 billion in 2015 and is likely to reach USD 5.02 billion in 2022, expanding at CAGR of 18.02% between 2015 and 2022. Asia pacific region was the leading chitosan market with an estimated market size of 8050 MT in 2011 and is projected 15010 MT in 2015. The U.S. has represented the second largest market in 2015 and is expected to reach in billions by 2022.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2269
Key Players:
The key players in market includes Heppe Medical Chitosan GmbH (Germany), Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China), Novamatrix (Norway), Agratech International, Inc. (U.S.), Golden-Shell Pharmaceutical Co. Ltd. (China), Qingdao Yunzhou Biochemistry Co. Ltd. (China), Panvo Organics Pvt Ltd. (India), Kitozyme S.A. (Belgium), Primex ehf (Iceland) and others.
Study Objectives of Chitosan Market:
Key Points from Table of Content:
10. Company Profiles
10.1 Heppe Medical Chitosan GmbH
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Development
10.2 Advanced Biopolymers AS
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.2.5 Recent Development
10.3 Biophrame Technologies
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Development
10.4 Novamatrix
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Development
10.5 Agratech International
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Development
Make an Enquiry before buying @ https://www.marketresearchfuture.com/enquiry/2269
Globally, the Chitosan Market is growing at a CAGR of 18.02% during forecasted period (2016-2022). Chitosan is produced commercially deacetylation of chitin, which is the structural element in the exoskeleton of crustaceans namely shrimps, oyster, crabs and other mollusk shells and cell wall of fungi. Besides , the properties of chitosan are antibacterial, anti-fungal and anti-viral due to these properties they are driving the market, application is huge in pharmaceutical industry namely, wound dressings, surgical sutures and as aids in cataracts surgery and periodontal diseases treatment. Availability of chitosan is enormous in nature, it ranks second as the most plentiful organic compound on earth. Chitosan has many properties that make them attractive for application from food, nutrition, cosmetics, biomedicine, and agriculture.
Globally, Chitosan Market was valued at USD 2.05 billion in 2015 and is likely to reach USD 5.02 billion in 2022, expanding at CAGR of 18.02% between 2015 and 2022. Asia pacific region was the leading chitosan market with an estimated market size of 8050 MT in 2011 and is projected 15010 MT in 2015. The U.S. has represented the second largest market in 2015 and is expected to reach in billions by 2022.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2269
Key Players:
The key players in market includes Heppe Medical Chitosan GmbH (Germany), Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China), Novamatrix (Norway), Agratech International, Inc. (U.S.), Golden-Shell Pharmaceutical Co. Ltd. (China), Qingdao Yunzhou Biochemistry Co. Ltd. (China), Panvo Organics Pvt Ltd. (India), Kitozyme S.A. (Belgium), Primex ehf (Iceland) and others.
Study Objectives of Chitosan Market:
- To study detail of Chitosan market by source, by application and by region in forecasted period 2022.
- To identify the market dynamics of Chitosan market dynamics by drivers, restrains, opportunities and challenges.
- To analyze various factors like Value chain analysis and porters five forces model.
- To provide historical and forecast revenue of market segment with respect to North America, Europe, APAC and RoW.
- To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
- To track mergers and acquisitions, strategic alliances, new product development of specified company.
Key Points from Table of Content:
10. Company Profiles
10.1 Heppe Medical Chitosan GmbH
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Development
10.2 Advanced Biopolymers AS
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.2.5 Recent Development
10.3 Biophrame Technologies
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Development
10.4 Novamatrix
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Development
10.5 Agratech International
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Development
Make an Enquiry before buying @ https://www.marketresearchfuture.com/enquiry/2269
No comments:
Post a Comment